3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
6
Neoplasms
1
Mesothelioma, Malignant
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Interventions
Bevacizumab
21
Paclitaxel
19
Carboplatin
15
pembrolizumab
14
Specimen Handling
14
liposomal doxorubicin
12
Magnetic Resonance Spectroscopy
12
Cyclophosphamide
11
olaparib
10
Gemcitabine
10
fludarabine
9
Topotecan
8
Biopsy
8
Fulvestrant
7
niraparib
6
Nivolumab
6
palbociclib
5
Taxes
5
Immunoglobulin G
5
Doxorubicin
5
Disulfides
5
aldesleukin
4
Oxaliplatin
4
trastuzumab deruxtecan
3
mirvetuximab soravtansine
3
binimetinib
3
Leucovorin
3
Fluorouracil
3
Cisplatin
3
AZD5305
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Brentuximab Vedotin
×
30 days
×
Clear all
No trials found.